Found 30 matching trials
A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors PHASE1 This is a multi-center, open-label, phase Ib/II study. First, the aim of th...
Show More Location
Massachusetts General Hospital Mass General 2
Learn More & Join Trial
Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma N/A Despite improvements in outcomes for patients with localized Ewing sarcoma,...
Show More Status
No Longer Available
Location
Multiple Locations
Learn More & Join Trial
QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors PHASE1 To assess the safety, tolerability, and pharmacokinetic profiles of AMG 479...
Show More Location
Multiple Locations
Learn More & Join Trial
Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) PHASE2 The purpose of this protocol is to allow continued treatment with conatumum...
Show More Learn More & Join Trial
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer PHASE2 The purpose of this study is to further advance the ability to practice per...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Study to Evaluate Mechanisms of Acquired Resistance to Panitumumab PHASE2 This study is designed to evaluate the mechanism(s) of resistance to the an...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors PHASE1 The purpose of this study is to test the safety of the combination of two d...
Show More Location
Indiana University Melvin and Bren Simon Cancer Center
Learn More & Join Trial
AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors PHASE2 The purpose of this research study is to determine the effectiveness of AMG...
Show More Location
H. Lee Moffitt Cancer Center
Learn More & Join Trial
Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC) PHASE1 This study is a global, multicenter, open-label phase 1b and randomized, do...
Show More Location
Multiple Locations
Learn More & Join Trial
Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma NA This early phase I trial studies the side effects of implanting and removin...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial